1993 …2023
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 3 Similar Profiles
Hemophilia A Medicine & Life Sciences
Factor VIII Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Healthy Volunteers Medicine & Life Sciences
von Willebrand Diseases Medicine & Life Sciences
Partial Thromboplastin Time Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1993 2023

Research Output 1997 2019

von Willebrand Factor
B-Cell Chronic Lymphocytic Leukemia
Stem Cells
Transplants
Antibodies
1 Citation (Scopus)

Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation

Hegerova, L., Bachan, A., Cao, Q., Vu, H. X., Rogosheske, J., Reding, M. T., Brunstein, C. G., Arora, M., Ustun, C., Vercellotti, G. M. & Bachanova, V., Dec 1 2018, In : Biology of Blood and Marrow Transplantation. 24, 12, p. e20-e25

Research output: Contribution to journalArticle

Stem Cell Transplantation
Lymphoma
Thrombosis
Catheters
Cell Transplantation
4 Citations (Scopus)
Plasma Exchange
Cardiopulmonary Bypass
Critical Illness
Thrombocytopenia
Heparin
14 Citations (Scopus)

Effect of late prophylaxis in hemophilia on joint status: a randomized trial

Manco-Johnson, M. J., Lundin, B., Funk, S., Peterfy, C., Raunig, D., Werk, M., Kempton, C. L., Reding, M. T., Goranov, S., Gercheva, L., Rusen, L., Uscatescu, V., Pierdominici, M., Engelen, S., Pocoski, J., Walker, D. & Hong, W., Nov 1 2017, In : Journal of Thrombosis and Haemostasis. 15, 11, p. 2115-2124 10 p.

Research output: Contribution to journalArticle

Hemophilia A
Joint Diseases
Joints
Hemorrhage
Least-Squares Analysis
7 Citations (Scopus)

Efficacy and safety of a VWF/FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures

Srivastava, A., Serban, M., Werner, S., Schwartz, B. A., Kessler, C. M., Alkindi, S., Apte, S. J., Castaman, G., Gill, J. C., Hellmann, A., Kavakli, K., Kouides, P. A., Kuriakose, P., Lissitchkov, T., Ma, A., Mahlangu, J., Morfini, M., Neufeld, E. J., Peyvandi, F., Reding, M. & 8 others, Rodriguez, N. I., Ross, C., Rusen, L., Shapiro, A., Uscatescu, V., Windyga, J., Zulfikar, B. & the Wonders Study Investigators, Mar 1 2017, In : Haemophilia. 23, 2, p. 264-272 9 p.

Research output: Contribution to journalArticle

von Willebrand Diseases
Type 3 Von Willebrand's Disease
Safety
Hemorrhage
Clinical Trials Data Monitoring Committees